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UbiquitylationThe Notch signaling pathway plays a crucial role in the regulation of cell fate decision, and is also a key
regulator of cell differentiation, including bone homeostasis, in a variety of contexts. However, the role of
Notch1 signaling in osteoclast differentiation is still controversial. In this study, we show that Receptor activator
of nuclear factor kappa-B ligand (RANKL)-induced osteoclast differentiation is promoted by the Notch1 intracel-
lular domain (Notch1-IC) and Ca2+/Calmodulin dependent protein kinase IV (CaMKIV) signaling. Notch1-IC pro-
tein level was augmented by CaMKIV through escape fromubiquitin dependent protein degradation. In addition,
CaMKIV remarkably increased Notch1-IC stability, and the kinase activity of CaMKIVwas essential for facilitating
Notch1 signaling. CaMKIV directly interactedwith Notch1-IC and phosphorylates Notch1-IC, thereby decreasing
proteasomal protein degradation through F-box and WD repeat domain-containing 7 (Fbw7). We also found
that Notch1-IC prevented inhibition of osteoclast differentiation by KN-93 but not the phosphorylation deﬁcient
formofNotch1-IC. These results suggest that phosphorylatedNotch1-IC byCaMKIV increasesNotch1-IC stability,
which enhances osteoclast differentiation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Receptor activator of NF-κB ligand (RANKL) stimulates osteoclast
differentiation in uncommitted cells of the monocyte-macrophage
lineage by interacting with its cell-surface receptor, Receptor activa-
tor of NF-κB (RANK) [1,2]. RANKL-RANK signaling is essential for os-
teoclast differentiation because both RANKL−/− and RANK−/− mice
do not develop osteoclasts [3,4]. The RANKL-RANK signaling pathway
activates transcription factors NF-κB, Fos, AP-1, and Nuclear factor of
activated T cells (NFATc1) [5–11]. The activity of these transcription
factors leads to the induction of osteoclast-speciﬁc genes, such as
tartrate-resistant acid phosphatase (TRAP), cathepsin-K, MMP9 and
calcitonin receptor [12–14]. RANKL induced CaMKIV activation is
required for the induction of NF-kB, c-Fos and NFATc1, which leads
to induction of osteoclast differentiation [15–17]. Intracellular Ca2+
signaling plays a critical role in a broad array of cell functions, includ-
ing transcription, cell cycle, apoptosis, exocytosis, and motility, and
often has multiple roles in cells [18]. Calcium regulates many func-
tions by forming a complex with calmodulin (CaM), upon the binding
of Ca2+/CaM increases its afﬁnity for its targets, which include the
Ca2+/CaM dependent Ser-Thr kinase (CaMK) family [19,20]. These ki-
nases have the general consensus phosphorylation sequence R-X-X-S/T,r, School of Biological Sciences
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rights reserved.Phosphorylation of CaMKIV by CaMKK increases CaMKIV kinase activity,
and activated CaMKIV translocates to the nucleus [18]. Nuclear CaMKIV
triggers the disruption of subnuclear domains containing class II histone
deacetylases (HDACs) and acts as a silencing mediator of retinoic acid
and thyroid hormone receptors (SMRT), a broad-speciﬁcity co-repressor
which represses nuclear hormone receptors and CBF1 [21]. These data
suggest the possibility that CaMKIV enhances Notch signaling [21].
Some studies have recently demonstrated that after RANKL stimula-
tion, mRNA and protein expression of Hes1 were up-regulated in
Raw264.7 cells [22–24]. Notch signaling in bone metabolism has
been shown to play a role in somitogenesis during skeletal devel-
opment, because several Notch family deﬁcient mice die during embryo-
genesis before bone formation [25–28]. Notch1 deﬁciency promotes
osteoclastogenesis indirectly by enhancing the ability of osteoblast line-
age cells to stimulate osteoclastogenesis. This is achieved by decreasing
the osteoprotegerin/RANKL expression ratio [29].
Notch, a highly conserved transmembrane protein, plays an essen-
tial role in the regulation of cell fate determination including bone
homeostasis [30–32]. Several downstream targets of Notch signaling
also have been identiﬁed, including the Enhancer of split [E(spl)]
complex genes and the mammalian homologues of the Hairy and
E(spl) genes, Hes1, Hes5, Hes7, Hey1, Hey2, and HeyL [33–42]. Asagiri
group demonstrated the requirement for NFATc1 in the generation of
osteoclasts in vivo by transferring NFATc1-deﬁcient hematopoietic stem
cells into c-Fos-deﬁcient mice [43]. Induction of Notch signaling by Jag-
ged1 or by ectopic expression of intracellular domain enhances NFATc1
promoter activity and expression and promotes osteoclastogenesis [23].
Multiple lines of evidence have indicated thatNotch signalingdysfunction
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Delta3 mutant mice (Pudgy) exhibit axial skeletal defects [44–46].
Notch activation by Delta1 reduces the surface levels of the Macrophage
colony-stimulating factor (M-CSF) receptor, c-Fms, in osteoclast precur-
sor cells and enhances the expression of osteoprotegerin (OPG) in stromal
cells, resulting in the downregulation of osteoclast differentiation [47].
Despite these observations, the precise mechanisms underlying the con-
nection between Notch signaling and the RANKL-CaMKIV mediated
osteoclastogenesis pathways are still largely unknown.
In this study, we demonstrate that Notch1-IC is regulated by
CaMKIV during osteoclast differentiation. The transcriptional activity
and the protein level of Notch1-IC were increased by CaMKIV via
inhibition of Notch1-IC proteasomal degradation through Fbw7. We
also determined that the up-regulated Notch1-IC by CaMKIV accelerates
osteoclast differentiation. Collectively, our ﬁnding suggests that CaMKIV
is crucial for the regulation of Notch1-IC in osteoclast differentiation.2. Materials and methods
2.1. Cell culture and transfection
Human embryonic kidney (HEK) 293 cells (ATCC No. CRL-1573)
were maintained in Dulbecco's modiﬁed Eagle's medium (DMEM,
Gibco-BRL) supplemented with 7% fetal bovine serum (FBS, Gibco-BRL)
and 1% penicillin/streptomycin (Gibco-BRL), Presenilin 1/2 double-
positive (PS1/2+/+), and Presenilin 1/2 double-negative (PS1/2−/−)
cells were maintained in DMEM supplemented with 10% FBS and 1%
penicillin/streptomycin in a humidiﬁed incubator with an atmosphere
containing 5% CO2. The mouse macrophage-like cell line Raw264.7
cells (ATCC No. TIB-71) were cultured in DMEM supplemented with
10% FBS and 1% penicillin/streptomycin in a humidiﬁed incubator with
an atmosphere containing 5% CO2. For plasmid DNA transfection, cells
were plated at a density of 2×106 cells/100-mm-diameter dish (SPL),
grown overnight, and transfected with the appropriate expression vec-
tors in the presence of the indicated combinations of plasmid DNAs by
using the calcium phosphate method or Lipofectamine (Invitrogen)
[17,48].2.2. Osteoclast differentiation and TRAP staining
RAW264.7 cells were plated at 1×105 cells/well in 96-well plates in
DMEMwith 10% FBS and were incubated overnight in a humidiﬁed in-
cubator. The medium was then replaced with α-minimal essential
medium (α -MEM, Gibco-RBL) containing 10% FBS and 20 ng/ml RANKL
(R&D systems) or RANKL plus either 5 μM KN93 (Sigma), or 5 μM DAPT
(Sigma). Culture media were replaced at least every second day with
fresh media containing the RANKL and appropriate concentrations of
CaMK inhibitor. After 4–5 days, cells were ﬁxed with ﬁxative solution
(Sigma) for 5 min, and thenwashed three times with PBS, and incubated
withmixtures containing naphthol AS-BI phosphate (Sigma), Fast Garnet
GBC Base Solution (Sigma), and Sodium Nitrite Solution (Sigma) in pres-
ence of Tartrate (Sigma) (Leukocyte Acid Phosphatase Assay Kit, Sigma).
TRAP-positive multinucleated cells containing three or more nuclei
were recorded by light microscopy [16,49].2.3. Site-directed mutagenesis
Site-directedmutagenesis of Notch1-IC cDNAwas performed using a
QuikChange kit (Stratagene), and the mutagenic primers were S2063A
(5′ CGCCCGTGAGGGCgcCTATGAGACTGCC-3′, S2173A (5′-CACGGAGG
AAGAAGgCC CAGGATGGCAAG-3′) (mismatches with the Notch1-IC
cDNA template are indicated by lowercase letters). The mutations
were veriﬁed by automatic DNA sequencing [48].2.4. Luciferase Reporter assay
The HEK293 cells, PS1/2+/+, and PS2−/− cells were cotransfected
with 4XCSL, Hes1, and Hes5-Luc and β-galactosidase together with
the indicated vector constructs. The cells were lysed in chemilumi-
nescent lysis buffer (18.3% of 1 M K2HPO4, 1.7% 1 M KH2PO4, 1 mM
phenylmethylsulfonyl ﬂuoride [PMSF], and 1 mM dithiothreitol [DTT])
and assayed for luciferase activity using a luciferase assay kit (Promega).
The activity of the luciferase reporter protein in the transfected cells was
normalized in reference to the β-galactosidase activity in the same cells
[50]. The data are expressed as the means±S.D. of triplicates from one
of three independent experiments. All of these results are representative
of at least three independent experiments.
2.5. GST-pull down assay
The recombinant GST-Notch1-IC protein was expressed in the E. coli
BL21 strain using the pGEX system, as indicated. The GST fusion protein
was then puriﬁed with GSH–agarose beads (Sigma) in accordance with
the manufacturer's instructions. An equal amount of GST or GST–
Notch1-IC fusion protein was incubated with the lysates of the HEK293
cells, which had been transfected for 4 h with combinations of expres-
sion vectors at 4 °C, with rotation. After incubation, the beads were
washed three times in ice-cold phosphate-buffered saline (PBS, pH 7.4)
and boiled with 20 μl of Laemmli sample buffer. The precipitates were
then separated via SDS-PAGE, and the pull-downproteinswere detected
via immunoblotting with speciﬁc antibodies [48].
2.6. Immunoblot analysis
After 48 h of transfection, the cultured HEK293 cells were
harvested and lysed in RIPA buffer [50 mM Tris–HCl (pH 7.5),
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1%
SDS, 1 mMphenylmethylsulfonyl ﬂuoride (PMSF), 1 mMdithiothreitol
(DTT) and 2 g/ml each of leupeptin and aprotinin] for 30 minutes at
4 °C. The cell lysates were subjected to 20 minutes of centrifugation at
12,000 g and 4 °C. The resultant soluble fraction was boiled in Laemmli
buffer and subjected to SDS-PAGE. After gel electrophoresis, the sepa-
rated proteins were transferred via electroblotting onto polyvinylidene
diﬂuoride (PVDF) membranes (Millipore). The membranes were
blocked with Tris-buffered saline solution (pH 7.4) containing 0.1%
Tween 20 and 5% nonfat milk. The blotted proteins were then probed
with anti-Myc antibody (9E10), anti-HA (12CA5) antibody, or anti-
FLAG M2 antibody (Sigma), and β-actin (Santa Cruz) followed by incu-
bation with anti-mouse horseradish peroxidase-conjugated secondary
antibodies (Amersham Biosciences). Membranes were also probed
with anti-Notch1-IC (Santa Cruz), anti-CaMKIV (Abcam) followed by
incubationwith anti-rabbit horseradish peroxidase-conjugated second-
ary antibodies (Santa Cruz). The blots were developed using enhanced
chemiluminescence (Anigene).
2.7. Protein stability assay
In the protein stability assay, cells were seeded at a density of
50–60% conﬂuence and incubated overnight. The cells were treated
with 0.1 mM cycloheximide for 0, 1, 2, 4 or 8 h to block the synthesis
of new proteins. Cells were collected at each time point and the total
lysates were then lysed in RIPA or Laemmli buffer. Protein levels of
Notch1 were determined by immunoblotting with anti-Myc at dilu-
tions of 1:3000 [51].
2.8. Coimmunoprecipitation assays
The cells were lysed in 1 ml of radioimmunoprecipitation Assay
(RIPA) buffer for 30 min at 4 °C. After centrifugation at 12,000 ×g for
20 min, supernatants were subjected to immunoprecipitation with the
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immunoprecipitates were washed three times with phosphate-buffered
saline (PBS; pH 7.4). Laemmli sample buffer was then added to the
immunoprecipitated pellets. The pellets were heated at 95 °C for 5 min
and then analyzed by sodiumdodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE).Westernblottingwasperformedwith the indicated
antibodies [52].
2.9. Immunocomplex kinase assay
To analyze the kinase activity, conﬂuent cells were harvested and
lysed in lysis buffer. Cell lysates were then subjected to 10 min of cen-
trifugation at 12,000 ×g and 4 °C. The soluble fraction was incubated
for 1 h with appropriate antibodies against the indicated protein ki-
nases at 4 °C. The immunocomplexes were then coupled to protein
G-agarose during an additional 1 h of incubation at 4 °C, after which
they were pelleted by centrifugation. The immunopellets were rinsed
three times with lysis buffer and then twice with 20 mM HEPES, at a
pHof 7.4. Immunocomplex kinase assayswere conducted by incubation
of the immunopellets for 30 min at 30 °C with 2 μg of substrate pro-
teins in 20 μl reaction buffer containing 0.2 mM sodium orthovanadate,
10 mMMgCl2, 2 μCi [γ32P] ATP, 20 mMHEPES (pH 7.4). Phosphorylat-
ed substrates were then visualized by SDS-PAGE and quantiﬁed using a
Fuji FLA 7000 phosphorimager [50].
2.10. Immunoﬂuorescence staining
Assays were conducted as previously described with HEK293 cells
plated at a density of 1×105 cells per well onto coverslips (Fisher)
[48]. The cultured cells were ﬁxed with 4% paraformaldehyde (Sigma)
in phosphate-buffered saline (PBS), and then permeabilized with 0.1%
Triton X-100 in PBS. Cells were blocked in 1% BSA in PBS. anti-Myc an-
tibody and anti-FlagM2 antibody (Sigma) were used as the primary an-
tibodies at a dilution of 1:100 and the cells were washed three times in
PBS. Mouse secondary antibodies conjugated to Alexa Fluor 488, and
Alexa Fluor 532 (Invitrogen) was added and the DNA dye ToPro3 was
used for nuclear localization. The stained cells were evaluated for local-
ization using confocalmicroscopy (Leica TCS SPE). For each experiment,
at least 300 cells were examined, and the images shown here represent
the typical staining pattern observed for a majority of cells.
2.11. Cloning and preparation of recombinant proteins
A full-length mouse CaMKIV gene, a mouse Notch1 gene, and dele-
tion mutants were constructed via PCR and inserted into either the
mammalian expression vector p3XFlag-CMV (Sigma) or the bacterial
expression vector pGEX4T-3 (Amersham Pharmacia). The Notch1-IC
deletion mutants constructed for the present study were Notch1-IC-
RAM-ANK (amino acid residues 1744 to 2110), Notch1-IC-RAM (amino
acid residues 1744 to 1870), Notch1-IC-OPA (amino acid residues 2076
to 2369), and Notch1-IC-PEST (amino acid residues 2369 to 2531).
The Myc-tagged Notch1-IC (pCS2-Myc-Notch1-IC), 4xCSL-Luc, Hes1-
Luc and Hes5-Luc were a kind gifts from Raphael Kopan (Washington
University, St. Louis, MO). Expression of the recombinant glutathione
S-transferase (GST) fusion proteins within the transformed bacteria
was induced using 1 mM isopropyl-β-D-thiogalactopyranoside (Sigma).
GST fusion proteins were puriﬁed with glutathione (GSH)-agarose
beads (Sigma), in accordance with the manufacturer's instructions.
3. Results
3.1. CaMKIV and Notch1 are required for RANKL-induced
osteoclast differentiation
RANKL is a ligand for osteoprotegerin and functions as a key factor for
osteoblast differentiation and activation. To conﬁrm the effect of RANKLon osteoclast differentiation, Raw264.7 cells were stimulated with
recombinant RANKL. The number of large multinucleated tartrate-
resistant acid phosphatase (TRAP)-positive osteoclasts increased after
RANKL treatment, suggesting that RANKL was sufﬁcient to promote os-
teoclast differentiation (Fig. 1A). The CaMKIV protein is expressed in
osteoclast precursor cells and activated after RANKL stimulation and
thereby crucial for osteoblast differentiation and function [15]. To clarify
the role of endogenous CaMKIV in the regulation of RANKL induced
osteoclastogenesis, we assessed the effects of the CaMKIV inhibitor on
the RANKL induced osteoclast differentiation. Coincident with previous
report, inhibition of CaMKIV by the general CaMKs inhibitor KN-93
suppressed the formation of TRAP-positive multinucleated osteoclast
(Fig. 1B). The role of endogenousNotch1 in theRANKL-inducedosteoclast
differentiation was further evaluated by the knockdown of Notch1 using
N-[N-(3,5-diﬂuorophenylacetyl-l-alanyl)]-S-phenylglycine t-butylester
(DAPT), which is a gamma-secretase inhibitor. DAPT was shown to efﬁ-
ciently block the presenilin/gamma-secretase complex [53] and, conse-
quently, it efﬁciently prevents activation of the Notch response [54,55].
We then assessedwhether DAPT regulates RANKL-induced osteoclast dif-
ferentiation. Inhibition of Notch1-IC generation using DAPT suppressed
the formation of TRAP-positive multinucleated osteoclast (Fig. 1B). The
role of endogenous Notch1 in RANKL-induced osteoclast differentiation
was further evaluated by the knockdown of Notch1 using short interfer-
ence Notch1. Unlike what was observed in the control short interference
plasmid-transfected cells, the cells transfected with short interference
Notch1 showed low expression levels of Notch1 (data not shown).
TRAP-positive multinucleated cells, which were stimulated by RANKL,
were down regulated through the knock-down of Notch1 expression
(Fig. 1C). These results indicate that the level of CaMKIV and Notch1-IC
might affect RANKL-induced osteoclast differentiation.
3.2. CaMKIV increases the transcriptional activity of Notch1 target genes
To determine whether CaMKIV is involved in regulating the tran-
scriptional activation of Notch1 target genes, a reporter assay was
performed with HEK293 cells using luciferase reporter genes. In this
experiment, two types of luciferase reporter genes were evaluated
under the control of the Hes1 promoter (Hes1-Luc) and the artiﬁcial
four-time repeat of the CSL (4XCSL-Luc) binding sequence. We inves-
tigated the effect of CaMKIV on Notch1-IC transcriptional activity. The
HEK293 cells were transfected with 4XCSL-Luc and either Notch1-IC
or an empty vector. As expected, Notch1-IC-mediated transcriptional
activity was increased in these samples. The Notch1-IC induced
4XCSL luciferase reporter activity was increased by cotransfection
with CaMKIV in a dose-dependent manner (Fig. 2A). We also ob-
served similar results using the Hes1-Luc reporter systems (Fig. 2B).
To determine the effect of CaMKIV in the absence and presence of en-
dogenous Notch1-IC, a transcription reporter assay was performed
using PS1/2+/+ and PS1/2−/− MEF cells. The transcriptional activity
of Notch1-IC after CaMKIV treatment gradually increased in both
PS1/2+/+ and PS1/2−/− MEF cells. (Fig. 2C, D). These data demon-
strate that CaMKIV could activate Notch1 reporter activity despite
the absence of Notch1-IC generation, suggesting that CaMKIV, at least
in part, could regulate Notch1 target gene expression in a Notch1-IC in-
dependent manner. However, the absolute value of three reporter sys-
tems was higher in PS1/2+/+ MEF cells than PS1/2−/− MEF cells,
suggesting that Notch1-IC and CaMKIV has a synergic effect on
Notch1 reporter activity. To investigate whether the transcriptional ac-
tivation of endogenous Notch1 target genes by CaMKIV occurs through
a RBP-Jk dependent manner, a transcription reporter assay was per-
formed using the dominant negative form of RBP-Jk (RBP-Jk-DN). In
the luciferase reporter gene assay with PS1/2−/− cells, RBP-Jk DN was
co-transfected with CaMKIV, and the effect of this transfection on the
transcriptional activation of Notch1 target genes was then assessed
using 4XCSL-Luc, Hes1-Luc. The transcriptional activity of Notch1-IC
was increased by CaMKIV, and down-regulated by cotransfection with
Fig. 1. CaMKIV and Notch1 are required for RANKL-induced osteoclast differentiation. (A) Raw264.7 cells were plated in 96-well plates and cultured in complete medium in the
presence of 20 ng/ml of RANKL. (B) Raw264.7 cells were plated in 96-well plates and cultured in complete medium in the presence of 20 ng/ml of RANKL, 5 μM of KN93, and
5 μM of DAPT as indicated. (C) Raw264.7 cells were transfected with expression vectors for si-Control or si-Notch1 for 48 h and plated in 96-well plates and cultured in complete
medium in the presence of 20 ng/ml of RANKL. (A-C) After 4–6 days, the cells were ﬁxed with 3.8% paraformaldehyde and osteoclasts were detected by staining for
Tartrate-resistant acid phosphatase (TRAP). All results were representative of at least three independent experiments.
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using theHes5-Luc reporter systems (data not shown). These results in-
dicated that the increase in the transcriptional activity of Notch1-IC by
CaMKIV was independent of Notch1-IC and dependent on RBP-Jk.
3.3. Notch1-IC interacts directly with CaMKIV in intact cells
Given that our results suggest that Notch1-IC is a target of CaMKIV,
we next investigated whether these two proteins interact physically
in intact cells. In the in vitro binding studies, puriﬁed GST and GST-
Notch1-IC proteins were immobilized on GSH-agarose. Cell lysates
expressing Flag-CaMKIV were incubated either with immobilized GST
or with GST-Notch1-IC on GSH-agarose. The interaction between GST-
Notch1-IC and CaMKIV was detected on bead complexes (Fig. 3A).
HEK293 cells were cotransfected with vectors encoding Flag-tagged
CaMKIV and Myc-tagged Notch1-IC and were then subjected to
coimmunoprecipitation analysis. Immunoblot analysis of Flag immuno-
precipitates from the transfected cells with an anti-Myc antibody re-
vealed that Flag-CaMKIV physically associated with Myc-Notch1-IC in
the cells (Fig. 3B). We examined whether endogenous CaMKIV and
Notch1-IC could interact in intact cells. Immunoblot analysis of the
CaMKIV immunoprecipitates using an anti-Notch1-IC antibody indicat-
ed that endogenous CaMKIV and Notch1-IC were physically associated
in intact cells (Fig. 3C).We also examinedwhether endogenous CaMKIV
and Notch1-IC could interact during RANKL-induced osteoclast differ-
entiation. Immunoblot analysis of the CaMKIV immunoprecipitates
using an anti-Notch1-IC antibody indicated that endogenous CaMKIV
and Notch1-IC were physically associated during RANKL-inducedosteoclast differentiation in Raw264.7 cells (Fig. 3D). Immunoﬂuores-
cence staining was performed to verify the subcellular localization of
CaMKIV and Notch1-IC. HEK293 cells were transfected with vector
encoding Myc-tagged Notch1-IC, Flag-tagged CaMKIV. Notch1-IC is lo-
calized mainly in the nucleus, and CaMKIV is distributed in both the
nucleus and cytoplasm.We then attempted to assess the subcellular lo-
calization of CaMKIV within HEK293 cells in the presence of Notch1-IC.
When the cells were coexpressed with Notch1-IC, CaMKIV had slightly
accumulated in the nucleus (Fig. 3E). These data indicate that Notch1-IC
and CaMKIV may exist within the same compartment. Notch1-IC has
a CDC 10/Ankyrin domain that includes a RAM domain and seven
Ankyrin repeats, anOPAdomain and a PEST domainwithin its structure.
We investigatedwhich of these domainsmight be involved in the inter-
action between Notch1-IC and CaMKIV. We used a variety of Flag-
tagged Notch1 deletion mutant: Notch1-IC-N (CDC 10/ANK domain),
Notch1-IC-ΔNΔC (OPA domain), or Notch1-IC-C (PEST domain). We
performed coimmunoprecipitation using three Notch1-IC deletion mu-
tants and endogenous CaMKIV. Our results show that CaMKIV bound to
the Notch1-IC-N mutant that contained RAM-ANK but not to the mu-
tants that contained either the OPA or PEST domains (Fig. 3F). In these
experiments, we demonstrated that Notch1-IC physically interacts
with CaMKII via the N-terminal CDC 10/Ankyrin domain.
3.4. CaMKIV up-regulates the Notch1-IC protein stability
To observe the effects of CaMKIV on the molecular interactions be-
tween Notch1-IC and RBP-Jk, coimmunoprecipitation was performed
by cotransfection of Myc-Notch1-IC, HA-RBP-Jk, and Flag-CaMKIV.
Fig. 2. CaMKIV increases the transcriptional activity of Notch1 target genes. (A) HEK293 cells were transfected with expression vectors for 4xCSL-Luc and β-galactosidase, along
with Notch1-IC and CaMKIV, as indicated. (B) HEK293 cells were transfected with expression vectors for Hes1-Luc and β-galactosidase, along with Notch1-IC and CaMKIV, as in-
dicated. (C, D) PS1/2+/+ and PS1/2−/− MEF cells were transfected with expression vectors for 4xCSL-Luc and Hes1-Luc, and β-galactosidase, along with CaMKIV as indicated.
(E) PS1/2−/− cells were transfected with expression vectors for 4xCSL-Luc and Hes1-Luc, and β-galactosidase, along with CaMKIV and the dominant negative form of RBP-Jk
(RBP-Jk-DN). (A–E) After 48 h of transfection, the cells were lysed and the luciferase activity determined. ANOVA, *Pb0.001.
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were cotransfected with CaMKIV, the band intensity corresponding to
the interaction between Notch1-IC and RBP-Jk was enhanced (Fig. 4A).
Immunoprecipitationwasperformed on cell lysates using an anti-HAan-
tibody and immunoblotting was performedwith the anti-Myc antibody.
Surprisingly, in the cell lysate immunoblot, the level of Notch1-IC protein
was up-regulated upon cotransfection with CaMKIV (Fig. 4A), which
shows that CaMKIV may regulate the steady state level of Notch1-IC
protein.
Next, HEK293 cells were subjected to western blot analysis to de-
termine whether CaMKIV plays a role in the regulation of the Notch1-
IC protein level. When HEK293 cells were cotransfected with Notch1-
IC and CaMKIV, the Notch1-IC protein level was found to be increased
by CaMKIV treatment in a dose-dependent manner (Fig. 4B). To de-
termine whether the kinase activity of CaMKIV plays a role in the
regulation of the Notch1-IC protein level, cells were cotransfected with
Myc-tagged Notch1-IC, Flag-tagged CaMKIV and Flag-tagged CaMKIV
K75E. The Notch1-IC protein level was shown to increase upon
cotransfection with CaMKIV but was decreased upon cotransfection
with the inactive form of CaMKIV (CaMKIV K75E) (Fig. 4C). This result
showed that the kinase activity of CaMKIV is essential for the regulation
of the Notch1-IC protein level. We determined the protein stability of
Notch1-IC using cycloheximide, an inhibitor of protein translation, in
the presence and absence of CaMKIV. After cycloheximide treatment,
the amount of Notch1-IC was analyzed by immunoblotting. The level
of Notch1-IC protein gradually decreased, where approximately half ofthe protein was degraded after 1 h in the absence of CaMKIV (Fig. 4D).
Upon cycloheximide treatment, the level of Notch1-IC protein slowly
decreased, where approximately half of the protein was degraded after
more than 6 h in the presence of CaMKIV (Fig. 4D). This result dem-
onstrated that Notch1-IC was slowly turned over in the presence of
CaMKIV.
3.5. CaMKIV positively regulates Notch1 signaling through an E3 ligase,
Fbw7
Given that our data suggest that CaMKIV regulates Notch1-IC pro-
tein stability. We next investigated whether CaMKIV regulates Notch1
protein stability through Fbw7. HEK293 cells were cotransfected with
vectors coding for Myc-tagged Notch1-IC, Flag-tagged CaMKIV, and
His-tagged Ubiquitin, and were then subjected to ubiquitylation analy-
sis. Immunoblot analysis of the His immunoprecipitates from the
transfected cells using an anti-Myc antibody showed that CaMKIV re-
duces the ubiquitylation of Notch1-IC in a dose-dependent manner
(Fig. 5A). Generally, the ubiquitylation of proteins leads to their rapid
degradation, and Notch1-IC is degraded by the ubiquitin-proteasome
system in the nucleus. Notch1-IC is ubiquitinated by the F-box protein
Fbw7/Sel-10/hCdc4/Ago, which was ﬁrst isolated during the genetic
screening of negative regulators of Notch in C. elegans [56].Weexpected
that CaMKIV might act as a mediator for the positive regulation of
Notch1-IC by Fbw7. When Fbw7 was cotransfected with Notch1-IC
and CaMKIV, the transcriptional activation of Notch1 was increased
Fig. 3. Notch1-IC interacts directly with CaMKIV in intact cells. (A) The Flag-CaMKIV expressing cell lysates were subjected to GST pull-down experiments with immobilized GST,
GST-Notch1-IC. Proteins bound to GST, GST-Notch1-IC were analyzed via immunoblotting with anti-Flag antibody. (B) HEK293 cells were transfected for 48 h with expression vec-
tors encoding Myc-Notch1-IC and Flag-CaMKIV, as indicated. After transfection, the cell lysates were subjected to immunoprecipitation with anti-Flag antibody. The immunopre-
cipitates were then immunoblotted with anti-Myc antibody, respectively. (C) HEK293 cells were lysed and subjected to immunoprecipitation with IgG and anti-Notch1-IC
antibodies, as indicated. The immunoprecipitates were immunoblotted with anti-CaMKIV antibody. (D) Raw264.7 cells were cultured in complete medium in the presence of
20 ng/ml of RANKL. After 2 days, the cells were lysed and subjected to immunoprecipitation with IgG and anti-Notch1-IC antibodies, as indicated. The immunoprecipitates were
immunoblotted with anti-CaMKIV antibody. (E) The cells were ﬁxed and CaMKIV and Notch1-IC were stained with Alexa Fluor 488 (green) and Alexa Fluor 555 (red) and examined
by confocal microscopy. White Scale bar, 25 μm. (F) HEK293 cells were transfected for 48 h with the indicated combinations of expression vectors for Flag-Notch1-IC,
Flag-Notch1-IC-N, Flag-Notch1-IC-ΔNΔC, Flag-Notch1-IC-C. The cell lysates then were subjected to immunoprecipitation with anti-Flag antibody, and the resulting precipitates
were subjected to immunoblotting analysis with anti-CaMKIV antibody.
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independent Notch1-IC degradation in Notch1-IC reporter activity
(Fig. 5B). To determine the effects of CaMKIV on the molecular interac-
tions between the constitutively active form of GFP-tagged Notch1
(ΔEN1-GFP) and Fbw7, coimmunoprecipitation was performed by
cotransfection of ΔEN1-GFP, Myc-Fbw7, and Flag-CaMKIV. Notch1-IC
and Fbw7 coimmunoprecipitated but when they were cotransfected
with CaMKIV, a band of Notch1-IC that interacted with Fbw7 decreased
(Fig. 5C). HEK293 cells were cotransfected with vectors coding for
Myc-tagged Notch1-IC, HA-tagged ubiquitin, GFP-tagged Fbw7, and
Flag-tagged CaMKIV, and were then subjected to ubiquitylation analy-
sis. Immunoblot analysis of the Myc immunoprecipitates from the
transfected cells with an anti-HA antibody showed that Fbw7 facilitated
the ubiquitylation of Notch1-IC, and CaMKIV decreases Fbw7-dependent
Notch1-IC ubiquitylation (Fig. 5D). These results suggest that CaMKIV
improves Notch1-IC protein stability by inhibiting the interaction be-
tween Fbw7 and Notch1-IC.3.6. CaMKIV-mediated phosphorylation of Notch1-IC inhibits the
degradation of Notch1-IC
Given that our results suggest that Notch1 is a target of CaMKIV,
we next investigated whether CaMKIV phosphorylates Notch1-IC.
CaMKIV preferentially phosphorylates substrate protein serine and
threonine residues that lie in an R-X-X-S/T. We conducted a kinase
assay with Flag-CaMKIV and puriﬁed GST-Notch1-IC. The Flag-CaMKIV
immunocomplexes prepared from cells catalyzed the phosphorylation
of puriﬁed recombinant GST-Notch1-IC, but not GST-Fbw7 (Fig. 6A).
In silico studies have shown that the Notch1-IC contains possible con-
served serine residues in vertebrates; these serine residues are accessi-
ble and located in the Ankyrin domain, and in front of the C-terminus of
Notch1-IC. This motif is present at amino acids 2060–2063, and 2170–
2173 of Notch1-IC. Furthermore, via site-directed mutagenesis, we de-
termined that the replacement of serine 2063, serine 2173, and serine
2063/2173 of Notch1-IC with alanine, caused a reduction in the in
Fig. 4. CaMKIV up-regulates the Notch1-IC protein stability. (A) HEK293 cells were transfected for 48 h with expression vectors encoding the indicated combinations of Myc-Notch1-IC,
HA-RBP-Jk, and Flag-CaMKIV. Cell lysates were subjected to immunoprecipitation with anti-HA antibody and the immunoprecipitates were immunoblotted with anti-Myc antibody. (B)
HEK293 cellswere transfected for 48 hwith expression vectors encoding the indicated combinations ofMyc-Notch1-IC and Flag-CaMKIV. (C) HEK293 cells were transfected for 48 hwith
expression vectors encoding the indicated combinations of Myc-Notch1-IC , Flag-CaMKIV, and Flag-CaMKIV K75E (catalytic inactive form). (D) HEK293 cells were transfected with
expression vectors encoding Myc-Notch1-IC and Flag-CaMKIV in the indicated combinations. HEK293 cells were treated with 100 μM cycloheximide (CHX) for the indicated periods
of time, and the cell lysates were immunoblotted with anti-Myc antibodies.
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noprecipitates (Fig. 6B). Moreover, we demonstrated that the Notch1-IC
mutant (S2173A) is resistant to CaMKIV-induced inhibition of Notch1-IC
degradation, which implies that the CaMKIV-induced phosphorylationFig. 5. CaMKIV positively regulates Notch1 signaling via an E3 ligase, Fbw7. (A) HEK293 cell
His-Ub as indicated. After 48 h of transfection, the cell lysates were incubated with Ni2+−NT
noprecipitates were then immunoblotted with an anti-Myc antibody. (B) HEK293 cells wer
4×CSL-Luc reporter in the indicated combinations. After 48 h of transfection, the cells were
transfected for 48 h with expression vectors encoding the indicated combinations of ΔEN1-
itation with anti-Myc antibody, and the immunoprecipitates were immunoblotted with an
Myc-Notch1-IC, HA-Ub, GFP-Fbw7, and Flag-CaMKIV as indicated. After 42 h of transfectio
were subjected to immunoprecipitation with anti-Myc antibodies. The immunoprecipitatesof Notch1-IC is crucial for the inhibition of theNotch1 protein degradation
(Fig. 6C). We then attempted to characterize the involvement of phos-
phorylation in the poly-ubiquitylation of Notch1-IC by Fbw7. HEK293
cells were co-transfected with vectors coding for Myc-tagged Notch1-IC,s were transfected with expression vectors encoding Myc-Notch1-IC, Flag-CaMKIV, and
A agarose beads to precipitate Histidinated (hence ubiquitinated) proteins. The immu-
e transfected with expression vectors encoding Notch1-IC, CaMKIV, and Fbw7 with the
lysed and the luciferase activity determined. ANOVA, *Pb0.001. (C) HEK293 cells were
GFP and Myc-RBP-Jk, and Flag-CaMKIV. Cell lysates were subjected to immunoprecip-
ti-GFP antibody. (D) HEK293 cells were transfected with expression vectors encoding
n, the cells were treated with MG132 (5 μM) for 6 h as indicated, and the cell lysates
were then immunoblotted with an anti-HA antibody.
Fig. 6. CaMKIV-mediated phosphorylation of Notch1-IC inhibits the degradation of Notch1-IC. (A) HEK293 cells were transfected with expression vectors encoding Flag-CaMKIV as
indicated. After 48 h of transfection, the cell lysates were subjected to immunoprecipitation with an anti-Flag antibody, and the resulting precipitates were examined for CaMKIV
kinase activity by an immune complex kinase assay using GST-Notch1-IC. (B) HEK293 cells were transfected with expression vectors encoding Flag-CaMKIV as indicated. After 48 h
of transfection, the cell lysates were subjected to immunoprecipitation with an anti-Flag antibody, and the resulting precipitates were examined for CaMKIV kinase activity by an
immune complex kinase assay using GST-Notch1-IC, GST-Notch1-IC (S2063A), GST-Notch1-IC (S2173A), and GST-Notch1-IC (S2063A/S2173A). (C) HEK293 cells were transfected
with expression vectors encoding Myc-Notch1-IC, Myc-Notch1-IC (S2173A), and Flag-CaMKIV as indicated. After 48 h of transfection, the cell lysates were subjected to immuno-
blotting with an anti-Myc and anti-Flag antibody. (D) HEK293 cells were transfected with expression vectors encoding Myc-Notch1-IC, Myc-Notch1-IC (S2173A), HA-Ub,
GFP-Fbw7, and Flag-CaMKIV as indicated. After 42 h of transfection, the cells were treated with MG132 (5 μM) for 6 h as indicated, and the cell lysates were subjected to immu-
noprecipitation with anti-Myc antibodies. The immunoprecipitates were then immunoblotted with an anti-HA antibody. (E) Raw264.7 cells were transfected with expression vec-
tors for Notch1-IC, Notch1-IC (S2173A) and treated CaMKIV inhibitor KN-93 as indicated. After 24 h, cells were cultured in complete medium in the presence of 20 ng/ml of RANKL.
After 4–5 days, the cells were ﬁxed with 3.8% paraformaldehyde and osteoclasts were detected by staining for Tartrate-resistant acid phosphatase (TRAP).
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Fbw7, and FLAG-tagged CaMKIV, and were then subjected to
ubiquitylation analysis. Immunoblot analysis of the anti-Myc anti-
body immunoprecipitates from the transfected cells with an anti-
HA antibody showed that CaMKIV and thewild type Notch1-IC reduced
the ubiquitylation of Notch1-IC and that mutant Notch1-IC increased
the ubiquitylation of Notch1-IC (Fig. 6D). These results showed that
the phosphorylation of Notch1-IC by CaMKIV is crucial to its augmenta-
tion of Notch1-IC stability. To determine the effect of phosphorylation of
Notch1-IC by CaMKIV on osteoclast differentiation, we performed TRAP
staining. RANKL-induced osteoclast differentiation was reduced by
KN93, and recovered by over-expression of Notch1-IC, but not recov-
ered by over-expression of Notch1-IC (S2173A) (Fig. 6E). These results
showed that phosphorylation of Notch1-IC by CaMKIV plays critical role
in the RANKL-induced osteoclast differentiation.
4. Discussion
RANKL stimulates osteoclast differentiation in uncommitted cells
of the monocyte-macrophage lineage by interacting with its cell-
surface receptor, receptor activator of NF-κB (RANK) [1,2]. Recent reports
have shown that the CaMKIV proteinwas expressed in osteoclast precur-
sor cells and activated after RANKL stimulation In addition CaMKIV, has
been shown to be crucial in regulating osteoclast differentiation and
acquisition of bone-resorbing activity [15–17]. Recent reports haveshown that RANKL induces mRNA and protein expression of Hes1,
a downstream target gene of the Notch1 signaling [22,24]. However,
themechanism behind this regulation has not been clearly established. In
this study, we demonstrated that RANKL-induced CaMKIV enhanced the
transcriptional activity of Notch1-IC, and the kinase activity of CaMKIV
was essential for this function. CaMKIV augmentedNotch1-IC protein sta-
bility by suppressing the proteasomal degradation of Notch1-IC proteins,
which induced osteoclast differentiation.
Although multiple lines of evidence indicate that Notch signaling
dysfunction results in bone disease, the speciﬁc role for Notch in regu-
lating osteoclastogenesis is still controversial. The possible involvement
of Notch signaling in osteoclastogenesis was examined through in vitro
and in vivo studies. Immobilized Delta-1 and constitutive active form of
Notch1 caused increased expression of RANKL and OPG genes and
strongly inhibited M-CSF gene expression, which negatively regulates
osteoclastogenesis [47]. Osteoblast speciﬁc deletion of both Notch1
and Notch2, and speciﬁc deletion of presenilin 1 and presenilin 2, re-
sults in the induction of RANKL expression and suppression of OPG
expression [57,58]. On the other hand, Notch 2, Jagged 1 and Hes 1
are up-regulated during RANKL-induced osteoclastogenesis [22–24].
Gamma-secretase inhibitor or Notch 2 short hairpin RNA suppresses
RANKL-induced osteoclastogenesis [23]. These results imply that
Notch signaling positively regulates osteoclastogenesis. Our results
demonstrated that a gamma-secretase inhibitor or Notch1 short hairpin
RNA suppressed RANKL-induced osteoclastogenesis, suggesting that
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differentiation. We also found that the CaMKs inhibitor inhibits
RANKL-induced osteoclast differentiation. These results suggest that
CaMKIV and Notch1 signaling play a critical role in the regulation of
osteoclastogenesis.
Several recent studies have shown that ubiquitination mediated
protein degradation plays a role in the regulation of Notch1 signaling
through degradation of Notch1 ligands, Notch1 itself, and RBP-Jk
[48,51,59,60]. This study provides the ﬁrst evidence that CAMKIV is
an endogenous positive regulator of the Notch signaling pathway by
preventing the degradation of the Notch1-IC proteins. When CAMKIV
activity was enhanced by RANKL, the Notch1 transcriptional activity
was signiﬁcantly increased in HEK293 cells. On the other hand, when
CAMKIV was overexpressed, the Notch1 transcriptional activity was
markedly increased in a dose-dependent manner. Our ﬁndings provide
unequivocal evidence that CAMKIV is an endogenous signaling agent
that up-regulates Notch1-IC transcriptional activity. Our result showed
that in vivo and in vitro binding between CaMKIV and Notch1-IC, and
the N-terminal domain of Notch1-IC, was critical to the binding of
CaMKIV. When Notch1-IC interacts with RBP-Jk, co-repressors dissoci-
ated, and formed a transcriptional active complex that activated RBP-
Jk-dependent transcription [30]. Our result showed that interaction be-
tweenNotch1-IC andRBP-Jkwas enhanced by CaMKIV due to improved
Notch1-IC protein stability.
Our ﬁndings reveal that CaMKIV kinase activity plays a crucial role
in the proteasomal degradation of Notch1-IC. Notch1-IC and Fbw7
contain a conserved consensus site that can bind to CaMKIV, and
Notch1-IC is phosphorylated by CaMKIV. Furthermore, we demon-
strated that CaMKIV mediated Notch1-IC phosphorylation of serineFig. 7. Schematic diagram for regulation of osteoclast differentiation by CaMKIV and Notch1
domain (Notch1-IC), followed by its nuclear translocation. The nuclear translocation of No
genes. The stability of Notch1-IC is regulated through its PEST (polypeptide enriched in p
8 (CDK8) and other kinases phosphorylate the Notch1-IC and facilitate Fbw7 dependent ubi
with costimulatory receptors to trigger an increase in Ca2+ concentration. An increased intr
(CaMKIV). CaMKIV interacts with Notch1-IC and phosphorylates Notch1-IC. Notch signaling
[23]. Surprisingly, phosphorylation of Notch1-IC by CaMKIV protects against the degradatio2173 resulted in an increase of the Notch1-IC protein level and de-
crease in the ubiquitylation of Notch1-IC. Therefore, phosphorylation
of Notch1-IC by CaMKIV is a possible mechanism that regulates
Notch1-IC signaling. However, in our earlier report, we showed that
phosphorylation on S2173 of Notch1-IC by ILK decreased the stability
of Notch1-IC through Fbw7 [48]. This raised the question of how does
the same phosphorylation site have two different functions? We as-
sumed that each signaling event occurred through different co-factors.
These different binding partners might have a different effect on the
same protein. This is still an unknown mechanism, and must be inten-
sively investigated. This study suggests a novel role of CaMKIV in increas-
ing Notch signaling. Because CaMKIV activation increases Notch1-IC
phosphorylation, it is expected to reduce Notch1-IC ubiquitylation and
degradation.
A recent report has shown that the CaMKIV protein was expressed
in osteoclast precursor cells and activated after RANKL stimulation. In
addition, CaMKIV was shown to be crucial in regulating osteoclast dif-
ferentiation, and acquisition of bone-resorbing activity [15,16]. We
have shown that RANKL induced osteoclast differentiationwas reduced
by KN93, DAPT. Notch signaling negatively or positively regulates oste-
oclast differentiation [22,23,29,44]. Especially, the Notch-dependent
Hes1 mRNA and protein expression level was increased in RANKL
stimulated osteoclast cells [22,23]. Our data demonstrated that RANKL
induced osteoclast differentiation was suppressed by KN93, and
recovered by Notch1-IC. However, the phosphorylation deﬁcient form
of Notch1-IC could not rescue osteoclast differentiation, suggesting
that RANKL-induced CaMKIV mediated phosphorylation of Notch1-IC
is critical for osteoclast differentiation. Previous reports have shown
that activated Notch signaling enhance the expression of NFATc1-IC. Notch1 proteins are activated by a series of cleavages that release its intracellular
tch1-IC recruits the transcription activator complex and drives transcription of target
roline, glutamate, serine and threonine) domain. Binding of cyclin-dependent kinase
quitylation and proteasomal degradation. After stimulation of RANKL, RANK cooperates
acellular Ca2+ concentration stimulates Ca2+/calmodulin-dependent protein kinase IV
enhances NFATc1 promoter activity and expression and promotes osteoclastogenesis
n of Notch1-IC via Fbw7 and thereby increases osteoclast differentiation.
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Notch1-IC acts as a positive regulator of osteoclast differentiation. There-
fore, our results demonstrated that CaMKIV increase RANKL-induced os-
teoclast differentiation by increasing Notch1-IC stability.
In summary, we have found that phosphorylation of Notch1-IC by
CaMKIV inhibits the proteasomal degradation of Notch1-IC through
Fbw7 (Fig. 7). The ﬁndings of this study indicate that up-regulated
Notch1-IC by CaMKIV accelerates osteoclast differentiation, and inhibi-
tors of CaMKIV and Notch1-IC could be therapeutic targets of bone dis-
eases, such as osteoporosis.Acknowledgments
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